Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Mark Lubberink"'
Autor:
Bo Lagerqvist, Essi Pikkarainen, Juhani Knuuti, Mark Lubberink, Jens Nørkær Sørensen, Tanja Kero, Antti Saraste
Publikováno v:
Journal of Nuclear Cardiology. 29:24-36
Background The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac 15O-water PET imaging in patients with suspected or known coronary artery disease (CAD). Methods Hyperemic myocardia
Autor:
Mika Teräs, Tuomas Kiviniemi, Miikka Tarkia, Paavo Halonen, Virva Saunavaara, Antti Kuivanen, Christoffer Stark, Juhani Knuuti, Tuula Tolvanen, Seppo Ylä-Herttuala, Antti Saraste, Mikko Pietilä, Tommi Vähäsilta, Timo Savunen, Anne Roivainen, Mark Lubberink, Maria Grönman, Jarmo Teuho
Background Assessment of myocardial viability is often needed in patients with chest pain and reduced ejection fraction. We evaluated the performance of reduced resting MBF, perfusable tissue fraction (PTF), and perfusable tissue index (PTI) in the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adccfdf716eaddefff6330d3e58b5d7d
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-392840
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-392840
Autor:
Meng-Xing Tang, Laura M. Schreiber, Johannes Martens, Robert Manka, Frank M. Bengel, Roxy Senior, Amedeo Chiribiri, Tobias Schaeffter, Mark Lubberink, Wenjia Bai, Konstantin Nikolaou, Sebastian Kozerke, Marc Kachelrieß, Klaus F. Kofoed, Stephan G. Nekolla, Andreas Kofler, Tim P. van de Hoef, Marc Dewey, Pál Maurovich-Horvat, Paul Knaapen, Maria Siebes, Florian Michallek, Jan J. Piek
Publikováno v:
Nature reviews. Cardiology, 17(7), 427-450. Nature Publishing Group
Nature Reviews Cardiology, 17(7), 427-450. Nature Publishing Group
Nature Reviews. Cardiology
Dewey, M, Siebes, M, Kachelrieß, M, Kofoed, K F, Maurovich-Horvat, P, Nikolaou, K, Bai, W, Kofler, A, Manka, R, Kozerke, S, Chiribiri, A, Schaeffter, T, Michallek, F, Bengel, F, Nekolla, S, Knaapen, P, Lubberink, M, Senior, R, Tang, M X, Piek, J J, van de Hoef, T, Martens, J, Schreiber, L & on behalf of the Quantitative Cardiac Imaging Study Group 2020, ' Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia ', Nature Reviews Cardiology, vol. 17, no. 7, pp. 427-450 . https://doi.org/10.1038/s41569-020-0341-8
2020, ' Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia ', Nature Reviews Cardiology, vol. 17, no. 7, pp. 427-450 . https://doi.org/10.1038/s41569-020-0341-8
Nature Reviews Cardiology, 17(7), 427-450. Nature Publishing Group
Nature Reviews. Cardiology
Dewey, M, Siebes, M, Kachelrieß, M, Kofoed, K F, Maurovich-Horvat, P, Nikolaou, K, Bai, W, Kofler, A, Manka, R, Kozerke, S, Chiribiri, A, Schaeffter, T, Michallek, F, Bengel, F, Nekolla, S, Knaapen, P, Lubberink, M, Senior, R, Tang, M X, Piek, J J, van de Hoef, T, Martens, J, Schreiber, L & on behalf of the Quantitative Cardiac Imaging Study Group 2020, ' Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia ', Nature Reviews Cardiology, vol. 17, no. 7, pp. 427-450 . https://doi.org/10.1038/s41569-020-0341-8
2020, ' Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia ', Nature Reviews Cardiology, vol. 17, no. 7, pp. 427-450 . https://doi.org/10.1038/s41569-020-0341-8
Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinical reference standard for the quantification of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6920992bffffd2fd65fc38a86187a5
http://hdl.handle.net/10044/1/77307
http://hdl.handle.net/10044/1/77307
Autor:
Peter Magnusson, Hendrik J. Harms, Mark Lubberink, Fredrik Gadler, Jens Nørkær Sørensen, Jonny Nordström, Stellan Mörner
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 26, Iss, Pp-(2020)
Magnusson, P, Nordström, J, Harms, H J, Lubberink, M, Gadler, F, Sörensen, J & Mörner, S 2020, ' Positron emission tomography ( 15 O-water, 11 C-acetate, 11 C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy ', IJC Heart and Vasculature, vol. 26, 100452 . https://doi.org/10.1016/j.ijcha.2019.100452
Magnusson, P, Nordström, J, Harms, H J, Lubberink, M, Gadler, F, Sörensen, J & Mörner, S 2020, ' Positron emission tomography ( 15 O-water, 11 C-acetate, 11 C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy ', IJC Heart and Vasculature, vol. 26, 100452 . https://doi.org/10.1016/j.ijcha.2019.100452
Background: The objectives of the study were to describe positron emission tomography (PET) parameters, using the tracers 15O-water at rest/stress, 11C-acetate, and 11C-HED, with regard to nonsustained ventricular tachycardia (NSVT) in hypertrophic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bf34797f6b99c5321862d344c52922a
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-411424
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-411424
Autor:
My Jonasson, Antoine Leuzy, Laure Saint-Aubert, Elena Rodriguez-Vieitez, Agneta Nordberg, Gunnar Antoni, Ove Almkvist, Mark Lubberink, Konstantinos Chiotis, Anders Wall, Irina Savitcheva
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo the regional load of tau pathology in Alzheimer's disease (AD) and other tauopathies. Eighteen patients with baseline investigations enroled in a 17-mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3dfe051c217296ffa568892409c08cc
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-322909
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-322909
Autor:
Irina Savitcheva, Elena Rodriguez-Vieitez, Antoine Leuzy, Ove Almkvist, Agneta Nordberg, Konstantinos Chiotis, Anders Wall, Gunnar Antoni, Mark Lubberink, My Jonasson, Laure Saint-Aubert
INTRODUCTION: Cross-sectional findings using the tau tracer [18F]THK5317 (THK5317) have shown that [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) data can be approximated using perfusion measures (early-frame standardized uptake val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24367ea2f6988494dee8f904a261644f
https://zenodo.org/record/1196511
https://zenodo.org/record/1196511
Autor:
Hendrik J. Harms, Paul Knaapen, Cornelis P. Allaart, Adriaan A. Lammertsma, Stefan de Haan, Albert D. Windhorst, Mark Lubberink, Robert C. Schuit, Marc C. Huisman
Publikováno v:
Journal of Nuclear Medicine, 56(11), 1706-1711. Society of Nuclear Medicine Inc.
Harms, H J, Lubberink, M, de Haan, S, Knaapen, P, Huisman, M C, Schuit, R C, Windhorst, A D, Allaart, C P & Lammertsma, A A 2015, ' Use of a Single C-11-Meta-Hydroxyephedrine Scan for Assessing Flow-Innervation Mismatches in Patients with Ischemic Cardiomyopathy ', Journal of Nuclear Medicine, vol. 56, no. 11, pp. 1706-1711 . https://doi.org/10.2967/jnumed.115.154377
Harms, H J, Lubberink, M, de Haan, S, Knaapen, P, Huisman, M C, Schuit, R C, Windhorst, A D, Allaart, C P & Lammertsma, A A 2015, ' Use of a Single C-11-Meta-Hydroxyephedrine Scan for Assessing Flow-Innervation Mismatches in Patients with Ischemic Cardiomyopathy ', Journal of Nuclear Medicine, vol. 56, no. 11, pp. 1706-1711 . https://doi.org/10.2967/jnumed.115.154377
Mismatch between areas of reduced myocardial blood flow (MBF) and reduced myocardial innervation (defect areas) may be used to estimate the risk for ventricular arrhythmias. The presence of a mismatch zone can be derived using a combined protocol con
Autor:
Adriaan A. Lammertsma, Jurriën M. ten Berg, Paul Knaapen, Tjeerd Germans, Iris K. Rüssel, Marco J.W. Götte, Folkert J. ten Cate, Albert C. van Rossum, Stefan A.J. Timmer, Mark Lubberink
Publikováno v:
American Journal of Cardiology, 107(10), 1522-1528. Elsevier Inc.
Timmer, S A J, Germans, T, Gotte, M J W, Rüssel, I K, Lubberink, J M, ten Berg, J M, ten Cate, F J, Lammertsma, A A, Knaapen, P & van Rossum, A C 2011, ' Relation of Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy to Contractile Dysfunction Independent from Myocardial Injury ', American Journal of Cardiology, vol. 107, no. 10, pp. 1522-1528 . https://doi.org/10.1016/j.amjcard.2011.01.029
Timmer, S A J, Germans, T, Gotte, M J W, Rüssel, I K, Lubberink, J M, ten Berg, J M, ten Cate, F J, Lammertsma, A A, Knaapen, P & van Rossum, A C 2011, ' Relation of Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy to Contractile Dysfunction Independent from Myocardial Injury ', American Journal of Cardiology, vol. 107, no. 10, pp. 1522-1528 . https://doi.org/10.1016/j.amjcard.2011.01.029
We studied the spatial relations among hyperemic myocardial blood flow (hMBF), contractile function, and morphologic tissue alterations in 19 patients with hypertrophic cardiomyopathy (HC). All patients were studied with oxygen-15 water positron emis
Autor:
Adriaan A. Lammertsma, Albert C. van Rossum, Tjeerd Germans, Arthur A.M. Wilde, Wessel P. Brouwer, Mark Lubberink, Jolanda van der Velden, Stefan A.J. Timmer, Imke Christiaans, Paul Knaapen
Publikováno v:
Timmer, S A J, Germans, T, Brouwer, W P, Lubberink, J M, van der Velden, J, Wilde, A A M, Christiaans, I, Lammertsma, A A, Knaapen, P & van Rossum, A C 2011, ' Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction ', European Journal of Heart Failure, vol. 13, no. 12, pp. 1283-1289 . https://doi.org/10.1093/eurjhf/hfr135
European Journal of Heart Failure, 13(12), 1283-1289. Wiley-Blackwell
European journal of heart failure, 13(12), 1283-1289. Wiley-Blackwell
European Journal of Heart Failure, 13(12), 1283-1289. Wiley-Blackwell
European journal of heart failure, 13(12), 1283-1289. Wiley-Blackwell
Aims Next to left ventricular (LV) hypertrophy, hypertrophic cardiomyopathy (HCM) is characterized by microvascular dysfunction and reduced myocardial external efficiency (MEE). Insights into the presence of these abnormalities as early markers of di
Autor:
Bart N.M. van Berckel, W. Peter Vandertop, Reina W. Kloet, Hedy Folkersma, Ronald Boellaard, Mark Lubberink, Adriaan A. Lammertsma
Publikováno v:
Journal of nuclear medicine, 50(12), 1975-1979. Society of Nuclear Medicine Inc.
Folkersma, I H, Boellaard, R, Vandertop, W P, Kloet, R W, Lubberink, M, Lammertsma, A A & van Berckel, B N M 2009, ' Reference Tissue Models and Blood-Brain Barrier Disruption: Lessons from (R)-[C-11]PK11195 in Traumatic Brain Injury ', Journal of Nuclear Medicine, vol. 50, no. 12, pp. 1975-1979 . https://doi.org/10.2967/jnumed.109.067512
Journal of Nuclear Medicine, 50(12), 1975-1979. Society of Nuclear Medicine Inc.
Folkersma, I H, Boellaard, R, Vandertop, W P, Kloet, R W, Lubberink, M, Lammertsma, A A & van Berckel, B N M 2009, ' Reference Tissue Models and Blood-Brain Barrier Disruption: Lessons from (R)-[C-11]PK11195 in Traumatic Brain Injury ', Journal of Nuclear Medicine, vol. 50, no. 12, pp. 1975-1979 . https://doi.org/10.2967/jnumed.109.067512
Journal of Nuclear Medicine, 50(12), 1975-1979. Society of Nuclear Medicine Inc.
(R)-[(11)C]PK11195 is a tracer for activated microglia. The purpose of this study was to assess the validity of the simplified reference tissue model for analyzing (R)-[(11)C]PK11195 studies in traumatic brain injury (TBI), where blood-brain barrier